149 related articles for article (PubMed ID: 21650457)
21. A new strategy for the development of highly potent and selective plasmin inhibitors.
Saupe SM; Steinmetzer T
J Med Chem; 2012 Feb; 55(3):1171-80. PubMed ID: 22276953
[TBL] [Abstract][Full Text] [Related]
22. Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability.
Hess S; Ovadia O; Shalev DE; Senderovich H; Qadri B; Yehezkel T; Salitra Y; Sheynis T; Jelinek R; Gilon C; Hoffman A
J Med Chem; 2007 Nov; 50(24):6201-11. PubMed ID: 17983214
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel 3,5-disubstituted pyridine as a potent, selective, and orally active inhibitor of Akt1 kinase.
Thomas SA; Li T; Woods KW; Song X; Packard G; Fischer JP; Diebold RB; Liu X; Shi Y; Klinghofer V; Johnson EF; Bouska JJ; Olson A; Guan R; Magnone SR; Marsh K; Luo Y; Rosenberg SH; Giranda VL; Li Q
Bioorg Med Chem Lett; 2006 Jul; 16(14):3740-4. PubMed ID: 16678413
[TBL] [Abstract][Full Text] [Related]
24. Impact of cis-proline analogs on peptide conformation.
Che Y; Marshall GR
Biopolymers; 2006 Apr; 81(5):392-406. PubMed ID: 16358327
[TBL] [Abstract][Full Text] [Related]
25. Identification of inhibitors of protein kinase B using fragment-based lead discovery.
Saxty G; Woodhead SJ; Berdini V; Davies TG; Verdonk ML; Wyatt PG; Boyle RG; Barford D; Downham R; Garrett MD; Carr RA
J Med Chem; 2007 May; 50(10):2293-6. PubMed ID: 17451234
[TBL] [Abstract][Full Text] [Related]
26. Geometric diversity through permutation of backbone configuration in cyclic peptide libraries.
Perlman ZE; Bock JE; Peterson JR; Lokey RS
Bioorg Med Chem Lett; 2005 Dec; 15(23):5329-34. PubMed ID: 16213707
[TBL] [Abstract][Full Text] [Related]
27. A novel substrate mimetic inhibitor of PKB/Akt inhibits prostate cancer tumor growth in mice by blocking the PKB pathway.
Litman P; Ohne O; Ben-Yaakov S; Shemesh-Darvish L; Yechezkel T; Salitra Y; Rubnov S; Cohen I; Senderowitz H; Kidron D; Livnah O; Levitzki A; Livnah N
Biochemistry; 2007 Apr; 46(16):4716-24. PubMed ID: 17397140
[TBL] [Abstract][Full Text] [Related]
28. Rapid evolution of 6-phenylpurine inhibitors of protein kinase B through structure-based design.
Donald A; McHardy T; Rowlands MG; Hunter LJ; Davies TG; Berdini V; Boyle RG; Aherne GW; Garrett MD; Collins I
J Med Chem; 2007 May; 50(10):2289-92. PubMed ID: 17451235
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and structure-activity relationship of 3,4'-bispyridinylethylenes: discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancer.
Li Q; Woods KW; Thomas S; Zhu GD; Packard G; Fisher J; Li T; Gong J; Dinges J; Song X; Abrams J; Luo Y; Johnson EF; Shi Y; Liu X; Klinghofer V; Des Jong R; Oltersdorf T; Stoll VS; Jakob CG; Rosenberg SH; Giranda VL
Bioorg Med Chem Lett; 2006 Apr; 16(7):2000-7. PubMed ID: 16413780
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of all-L cyclic tetrapeptides using pseudoprolines as removable turn inducers.
Fairweather KA; Sayyadi N; Luck IJ; Clegg JK; Jolliffe KA
Org Lett; 2010 Jul; 12(14):3136-9. PubMed ID: 20565133
[TBL] [Abstract][Full Text] [Related]
31. Restriction of a peptide turn conformation and conformational analysis of guanidino group using arginine-proline fused amino acids: application to mini atrial natriuretic peptide on binding to the receptor.
Sugase K; Horikawa M; Sugiyama M; Ishiguro M
J Med Chem; 2004 Jan; 47(2):489-92. PubMed ID: 14711318
[TBL] [Abstract][Full Text] [Related]
32. Docking of protein kinase B inhibitors: implications in the structure-based optimization of a novel scaffold.
Hernández-Campos A; Velázquez-Martínez I; Castillo R; López-Vallejo F; Jia P; Yu Y; Giulianotti MA; Medina-Franco JL
Chem Biol Drug Des; 2010 Sep; 76(3):269-76. PubMed ID: 20572809
[TBL] [Abstract][Full Text] [Related]
33. A tandem in situ peptide cyclization through trifluoroacetic acid cleavage.
Chandra K; Roy TK; Shalev DE; Loyter A; Gilon C; Gerber RB; Friedler A
Angew Chem Int Ed Engl; 2014 Sep; 53(36):9450-5. PubMed ID: 24827640
[TBL] [Abstract][Full Text] [Related]
34. Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluation.
Li Q; Li T; Zhu GD; Gong J; Claibone A; Dalton C; Luo Y; Johnson EF; Shi Y; Liu X; Klinghofer V; Bauch JL; Marsh KC; Bouska JJ; Arries S; De Jong R; Oltersdorf T; Stoll VS; Jakob CG; Rosenberg SH; Giranda VL
Bioorg Med Chem Lett; 2006 Mar; 16(6):1679-85. PubMed ID: 16403626
[TBL] [Abstract][Full Text] [Related]
35. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG-CoA reductase.
Pak VV; Koo M; Yun L; Kwon DY
J Mol Recognit; 2007; 20(3):197-203. PubMed ID: 17486664
[TBL] [Abstract][Full Text] [Related]
36. Vinyl ester-based cyclic peptide proteasome inhibitors.
Baldisserotto A; Marastoni M; Fiorini S; Pretto L; Ferretti V; Gavioli R; Tomatis R
Bioorg Med Chem Lett; 2008 Mar; 18(6):1849-54. PubMed ID: 18294845
[TBL] [Abstract][Full Text] [Related]
37. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of a novel cis-proline-derived cyclic type VI beta-turn mimic via ring-closing metathesis.
Boruah A; Rao IN; Nandy JP; Kumar SK; Kunwar AC; Iqbal J
J Org Chem; 2003 Jun; 68(12):5006-8. PubMed ID: 12790624
[TBL] [Abstract][Full Text] [Related]
39. Molecular dynamics simulations and elastic network analysis of protein kinase B (Akt/PKB) inactivation.
Cheng S; Niv MY
J Chem Inf Model; 2010 Sep; 50(9):1602-10. PubMed ID: 20735046
[TBL] [Abstract][Full Text] [Related]
40. A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera.
Davies TG; Verdonk ML; Graham B; Saalau-Bethell S; Hamlett CC; McHardy T; Collins I; Garrett MD; Workman P; Woodhead SJ; Jhoti H; Barford D
J Mol Biol; 2007 Mar; 367(3):882-94. PubMed ID: 17275837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
